CMPS Key Statistics, Chart & Performance
The current stock price of CMPS is 6.59 USD. In the past month the price increased by 0.46%. In the past year, price increased by 49.43%.
CMPS Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CMPS. When comparing the yearly performance of all stocks, CMPS is one of the better performing stocks in the market, outperforming 88.88% of all stocks.
CMPS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CMPS. Both the profitability and financial health of CMPS have multiple concerns.
CMPS Financial Highlights
Over the last trailing twelve months CMPS reported a non-GAAP Earnings per Share(EPS) of -2.86. The EPS decreased by -30% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -92.84% | ||
| ROE | -631.31% | ||
| Debt/Equity | 0.49 |
CMPS Forecast & Estimates
17 analysts have analysed CMPS and the average price target is 17.15 USD. This implies a price increase of 160.31% is expected in the next year compared to the current price of 6.59.
CMPS Ownership
CMPS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 23.88 | 398.83B | ||
| AMGN | AMGEN INC | 15.48 | 182.32B | ||
| GILD | GILEAD SCIENCES INC | 17.49 | 177.76B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 26.82 | 118.13B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.11 | 79.79B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 689.8 | 46.48B | ||
| INSM | INSMED INC | N/A | 33.52B | ||
| NTRA | NATERA INC | N/A | 31.42B | ||
| BIIB | BIOGEN INC | 10.56 | 25.93B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.12 | 20.59B | ||
| INCY | INCYTE CORP | 15.72 | 19.81B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.45B |
Related stock screener links
About CMPS
Company Profile
Compass Pathways Plc is a biotechnology company, which provides mental health care services. The company is headquartered in Altrincham, Cheshire and currently employs 166 full-time employees. The company went IPO on 2020-09-18. The firm is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. The company commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. The company also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Company Info
COMPASS PATHWAYS PLC
3Rd Floor, 1 Ashley Road
Altrincham CHESHIRE WA14 2DT GB
CEO: George Goldsmith
Employees: 166
Phone: 17166766461
COMPASS PATHWAYS PLC / CMPS FAQ
What does CMPS do?
Compass Pathways Plc is a biotechnology company, which provides mental health care services. The company is headquartered in Altrincham, Cheshire and currently employs 166 full-time employees. The company went IPO on 2020-09-18. The firm is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. The company commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. The company also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
What is the stock price of COMPASS PATHWAYS PLC today?
The current stock price of CMPS is 6.59 USD. The price decreased by -0.3% in the last trading session.
Does CMPS stock pay dividends?
CMPS does not pay a dividend.
What is the ChartMill rating of COMPASS PATHWAYS PLC stock?
CMPS has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the market expecting CMPS stock to perform?
17 analysts have analysed CMPS and the average price target is 17.15 USD. This implies a price increase of 160.31% is expected in the next year compared to the current price of 6.59.
How many employees does COMPASS PATHWAYS PLC have?
COMPASS PATHWAYS PLC (CMPS) currently has 166 employees.